Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zrl
    Junior Member
    • Mar 2014
    • 6

    #1

    When to amplify libraries for RNA-seq?

    Hi,

    I have a relatively basic question. I am performing RNA-seq on some small tissue samples and I have constructed my first set of libraries for Illumina sequencing using the Ovation/NuGen SPIA system. My libraries are at about 2ng/ul concentration, or around 6nM. My question is: how do you known when to do PCR amplification of your libraries? I think that my RNA is concentrated enough to cluster directly onto a flow cell, but I have been told that amplification is usually necessary for SPIA. On the other hand, I would like to reduce amplification bias as much as possible.

    Any recommendations here? Any rough guidelines that you use to determine whether to amplify or not?

    Thanks in advance, zrl
  • luc
    Senior Member
    • Dec 2010
    • 469

    #2
    Sorry, I have no experience with SPIA. If you can confirm your library concentration with qPCR (nanodrop, Qbit, and bioanalyzer are not good enough), PCR-free sequencing should be possible.
    What is the purpose of your experiments? In case you want to assess any kind of DGE, you should use protocols that you can maintain unchanged for future samples.

    Comment

    • zrl
      Junior Member
      • Mar 2014
      • 6

      #3
      Thanks for your input, luc. I do plan to look at DGE and will make sure to use a consistent protocol between all samples. I have only quantified with Qubit, and plan to use Kapa qPCR to validate.

      Comment

      • zrl
        Junior Member
        • Mar 2014
        • 6

        #4
        For the information of anyone else using SPIA: I have spoken to a couple researchers who have had significant difficulties sequencing their libraries when they have not done a PCR amplification following library prep. PCR helps enrich for fragments with both adapters, which might be the explanation.

        Comment

        • jwfoley
          Senior Member
          • Jun 2009
          • 183

          #5
          How did you add the sequencing adapters to the library after SPIA? Did you then select for successful products with adapters on both ends? Normally PCR takes care of that for you by diluting out the failures, but if you do no PCR then you have a problem, especially if you used ligation, which is very inefficient. Perhaps your library can still be sequenced, but at the very least you need to quantify sequenceable molecules in your product (by qPCR) because this will be less than the total mass. KAPA has a nice kit with standards for this.

          Comment

          • zrl
            Junior Member
            • Mar 2014
            • 6

            #6
            Originally posted by jwfoley View Post
            How did you add the sequencing adapters to the library after SPIA? Did you then select for successful products with adapters on both ends? Normally PCR takes care of that for you by diluting out the failures, but if you do no PCR then you have a problem, especially if you used ligation, which is very inefficient. Perhaps your library can still be sequenced, but at the very least you need to quantify sequenceable molecules in your product (by qPCR) because this will be less than the total mass. KAPA has a nice kit with standards for this.
            Thanks jwfoley. I did use ligation. I think that I now understand why PCR is necessary for enrichment of successful products, as well as why qPCR is also crucial. I do plan to use the Kapa kit to quantify.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            20 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            43 views
            0 reactions
            Last Post SEQadmin2  
            Working...